You just read:

Regeneron and Sanofi to Present New Phase 3 Praluent® (alirocumab) Injection Clinical Trial Analyses at ACC.17 Scientific Sessions

News provided by

Regeneron Pharmaceuticals, Inc.

07 Mar, 2017, 08:00 ET